000			03498nam a22005535i 4500
999			_c200456910 _d75122
003			TR-AnTOB
005			20231109085730.0
007			cr nn 008mamaa
008			220905s2022 sz | s |||| 0|eng d
020			_a9783031002410
024	7		_a10.1007/978-3-031-00241-0 _2doi
040			_aTR-AnTOB _beng _erda _cTR-AnTOB
060			_aQW 940
072		7	_aMMKL _2bicssc
072		7	_aMED015000 _2bisacsh
072		7	_aMKPL _2thema
096			_aQW940EBK
245	1	0	_aManaging Immunotherapy Related Organ Toxicities _h[electronic resource] : _bA Practical Guide / _cedited by Yinghong Wang.
250			_a1st ed. 2022.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022.
300			_a1 online resource
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aEndocrine toxicity -- Gastrointestinal toxicity -- Heart toxicity -- Kidney toxicity -- Liver toxicity -- Lung toxicity -- Muscular -- skeletal toxicity -- Neuro toxicity -- Pancreas toxicity -- Skin toxicity -- Emergency/Inpatient/Outpatient Workflow.
520			_aCertain organ toxicities can be severe and life-threatening. Therefore, it is crucial to recognize these disease entities early on to provide prompt and effective treatments to improve the quality of patient care, and enable the continuation of cancer therapy long-term. A clinical handbook with a particular focus in this field is lacking. This handbook focuses on the comprehensive, systematic review of clinical aspects of immunotherapy-induced toxicities in 15 major organ systems. The organs covered include endocrine, eye, gut, heart, kidney, liver, lung, muscular-skeletal, neuro, pancreas and skin etc. A unique feature about this book is the inclusion of perspectives from Anesthesiology, Infectious Disease, and Pathology besides specific organ toxicity management. The contributors are a group of experts offering routine clinical care to patients with most complex and refractory toxicity conditions, conducting pioneering research, and providing the guidance for the clinical practice to the peers and trainees in the field. The topics of each chapter include incidence, clinical presentations, evaluation, management, and long term follow up of each disease entity. There is also a simplified management algorithm or table illustrated in each chapter as well as audio PowerPoint slide deck to provide straightforward general instruction on the evaluation and treatment.
650		0	_aCritical care medicine.
650		0	_aImmunotherapy.
650		0	_aOncology.
650	1	4	_aIntensive Care Medicine.
650	2	4	_aImmunotherapy.
650	2	4	_aOncology.
653		0	_aImmunotherapy -- adverse effects
653		0	_aImmune Checkpoint Inhibitors -- adverse effects
653		0	_aImmune Checkpoint Inhibitors -- toxicity
653		0	_aNeoplasms -- drug therapy
653		0	_aDigestive System -- drug effects
653		0	_aSkin -- drug effects
700	1		_aWang, Yinghong. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
856	4	0	_uhttps://doi.org/10.1007/978-3-031-00241-0 _3Springer eBooks _zOnline access link to the resource
942			_2NLM _cEBK
041			_aeng